Bedminster, NJ – September 10, 2009 – Cegedim Dendrite, the world’s leading provider of life sciences-specific customer relationship management (CRM) solutions, today announced its evaluation in a comprehensive report by Gartner Research on life sciences, entitled “Key Opinion Leader (KOL) Management in the Life Sciences: Utilizing the Peer Channel to Educate and Inform Physicians.”
KOL insight, advice and endorsement can help reduce time to market and encourage prescription uptake. As physician access decreases, pressures to enhance transparency increase and sales force and marketing investments are reduced, strong KOL relationships become even more essential for companies.
Cegedim Dendrite’s Mobile Intelligence KOL Manager assists organizations in building and managing collaborative long-term thought leader relationships by allowing medical directors and MSLs to more effectively perform their daily activities through a single touch point, with access to essential meeting preparation tools, easy-to-use interaction management capabilities, and real-time outcomes reporting. Mobile Intelligence KOL Manager is a global solution specifically designed to adapt to clients’ regional, multi- or single-country needs.
According to Thibaut de Lataillade, Vice President, Global Marketing for Cegedim Dendrite, “This report clearly highlights that Cegedim Dendrite provides the most comprehensive, process-oriented and progressive option for life sciences companies seeking to improve their KOL management and reach.”
To download the full report, please visit the Cegedim Dendrite website
About Cegedim Dendrite
Cegedim Dendrite is the life sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Pharmaceutical by design, the company’s innovative business solutions and global reach incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Dendrite enables more than 200,000 users in many of the world’s top companies to stay ahead of market challenges. Cegedim Dendrite also provides sales, marketing and regulatory compliance solutions in more than 80 countries.
Cegedim Dendrite is part of the France-based Cegedim S.A. Group.
To learn more, please visit: www.cegedimdendrite.com.
About Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of €849 million in 2008. To learn more, please visit our website at www.cegedim.com.
Listed on NYSE Euronext Paris, compartment B – ISIN FR0000053506 – Reuters CGDM.PA – Bloomberg CGM.
Media Inquiries: